Rossmed Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 7.90 M
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.50 M
- Revenue Growth 15.29%
- Profit Growth 368.32%
- Ebitda 27.16%
- Net Worth 8.77%
- Total Assets 4.42%
About Rossmed Lifesciences
Rossmed Lifesciences Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 December 2003 and has a history of 21 years and one month. Its registered office is in Kozhikode, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 7.90 M.
The company has closed loans amounting to ₹5.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Elakkat Rajasekhar, Gopalapillai Reghu, Jahangeer Kalachalilakath, and Two other members serve as directors at the Company.
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232KL2003PTC016666
- Company No.
016666
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
What products or services does Rossmed Lifesciences Private Limited offer?
Rossmed Lifesciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Nutraceuticals & Dietary Supplements, Mineral Supplement, Ayurvedic,Herbal Products & Medicine, Herbal Piles Medicine, Digestive System Drugs & Medicines, Antacid Drugs, Hand Sanitizers & Personal Hygiene, Hair Shampoo.
Who are the key members and board of directors at Rossmed Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jahangeer Kalachalilakath  | Managing Director | 04-Dec-2003 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Elakkat Rajasekhar | Director | 04-Dec-2003 | Current |
| Gopalapillai Reghu | Director | 01-Feb-2005 | Current |
| Sreekumar Avinhikkati | Director | 04-Dec-2003 | Current |
| Na Udayakumar | Director | 20-Feb-2023 | Current |
Financial Performance of Rossmed Lifesciences.
Rossmed Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.29% increase. The company also saw a substantial improvement in profitability, with a 368.32% increase in profit. The company's net worth moved up by a moderate rise of 8.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rossmed Lifesciences?
In 2022, Rossmed Lifesciences had a promoter holding of 94.89% and a public holding of 5.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gynoreva Lifesciences Private LimitedElakkat Rajasekhar is a mutual person
- Rossmed Ultracare Private Limited
Jahangeer Kalachalilakath is a mutual person
Charges (Loans)
₹0
₹5.50 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.30 Cr
- Idbi Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Aug 2023 | Idbi Bank Limited | ₹2.50 M | Satisfied |
| 14 Sep 2012 | Hdfc Bank Limited | ₹3.00 M | Satisfied |
How Many Employees Work at Rossmed Lifesciences?
Rossmed Lifesciences has a workforce of 22 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rossmed Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rossmed Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.